leisure time -WSS

leisure time

author：leisure time 2025-08-19 20:47:36 - browse：976

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： UnitedHealth’s Optum accused of antitrust violations in California

WSS

What to do when lifesaving products contribute to climate change

Flagship Pioneering launches a new biotech in two countries

J&J to emphasize cancer drugs, stop much of its vaccine research

Takeda, Janssen join wearable maker to measure scratching

J&J to emphasize cancer drugs, stop much of its vaccine research

What don’t we know about an Alzheimer’s drug side effect?

hotspot

leisure time

Sign up for Morning Rounds

focus

Medicare details structure of new drug price negotiation program

Mayo Clinic plans $5B tech

At least 13 dead in Texas as scorching temps continue

As biotech industry slumps, bioscience job market is upside down

Virginia high school admissions case could be legal follow

UnitedHealth’s Optum accused of antitrust violations in California

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Medical records are filled with copy

STAT Summit: Meghan O’Rourke on making chronic illness visible

explore

STAT Summit: Meghan O’Rourke on making chronic illness visible

BIO selects John Crowley as new CEO

Smaller biotechs seek to piggyback on weight loss drug boom

Rep. Raul Ruiz on the physician shortage and more

How to pay for weight loss drugs and save Medicare

UnitedHealth, Optum discontinue NaviHealth name

hotspot

knowledge

knowledge

leisure time